Global Neurodegenerative Diseases Therapeutics Market 2018-2022| Increase in Aging Population to Drive Growth| Technavio

LONDON–(BUSINESS WIRE)–Technavio’s global neurodegenerative diseases therapeutics market
research report forecasts the market to grow at a CAGR of nearly 8%
during the forecast period.

The increase in aging population will be one of the major trends in the global
neurodegenerative diseases therapeutics market
2018-2022. Globally, there is an increase in the aging population due to
declining fertility and increasing longevity. Medicine has prolonged the
morbidity phase. This has increased the risk of developing neurological
disorders such as Alzheimer’s disease and Parkinson’s disease. As per
the United Nations, around 962 million people globally were reported to
be aged 60 years in 2017.

This report is available at a USD 1,000 discount for a limited time
market snapshot before purchasing

According to Technavio analysts, one of the key drivers for the global
neurodegenerative diseases therapeutics market is the strong drug
development pipeline:

Global neurodegenerative diseases therapeutics
market: Strong drug development pipeline

Globally, the prevalence and incidence of neurodegenerative diseases are
increasing. For instance, according to the CDC, Alzheimer’s disease
affected around five million people in the US in 2014 and is expected to
nearly triple to 14 million people by 2060. The major neurodegenerative
diseases include Alzheimer’s disease, Parkinson’s disease, Huntington’s
disease, and multiple sclerosis.

According to a senior analyst at Technavio for research on infectious
and rare diseases, “The incidence of Alzheimer’s disease and
Parkinson’s disease has been increasing rapidly. Thus, ongoing
developments in the market are focused on RD, which has led to a strong
drug development pipeline. There are several drugs in the pipeline that
could contribute to the growth of the market during the forecast period.”

Global neurodegenerative diseases therapeutics
market: Segmentation analysis

This global neurodegenerative diseases therapeutics market analysis
report provides market segmentation by indication (multiple sclerosis,
Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and
others) and by region (the Americas, APAC, and EMEA). This report
provides an in-depth analysis of the prominent factors influencing the
market, including drivers, opportunities, trends, and industry-specific

Of the four major segments by indication, the multiple sclerosis segment
held the largest neurodegenerative diseases therapeutics market share in
2017, contributing to over 41% of the market. This segment will dominate
the global market throughout the forecast period.

The Americas held the largest share of the market in 2017, accounting
for close to 52% share. It was followed by EMEA and APAC respectively.
The Americas is expected to dominate the market throughout the period

Looking for more information on this market? Request
a free sample report

Technavio’s sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market definition
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team